Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMOC2 is a secreted matricellular glycoprotein that belongs to the SPARC family. It plays a crucial role in promoting matrix assembly, endothelial cell proliferation, and angiogenesis. SMOC2 contains structural domains such as Kazal, thyroglobulin-like, and EF-hand calcium-binding domains. It is involved in various biological processes, including embryogenesis and wound healing, and its dysregulation has been associated with dental developmental defects and autoimmune conditions like vitiligo.
SMOC2's primary mechanism involves promoting matrix assembly and modulating cellular responses to angiogenic growth factors. It synergizes with factors like vascular endothelial growth factor and basic fibroblast growth factor to enhance angiogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPARC-related modular calcium binding protein 2 (SMOC2).